Navigation Links
Week-24 Interim Results From Phase 2b PILLAR Study to be Presented as Late-Breaker at AASLD
Date:10/30/2010

onse-guided criteria continued with peg-interferon and ribavirin until Week-48. TMC435 demonstrated potent antiviral activity, at week 4 (rapid virologic response (RVR)) and at week 12 (complete early virologic response (cEVR)) HCV RNA was undetectable (<25IU/ml) for the majority of patients. The viral breakthrough rate was 4.9 percent in the TMC435 treatment groups.

"Chronic infection with HCV is a leading cause of cirrhosis, liver cancer, and liver transplantation worldwide," said Dr Michael W. Fried M.D., lead clinical investigator and Professor of Medicine, Director of Hepatology, University of North Carolina at Chapel Hill. "We are extremely encouraged by these data for TMC435."

The goal of HCV treatment is to achieve SVR24, which means the virus remains undetectable in patients' blood six months after they have finished treatment. Patients who achieve SVR are considered cured. The current standard of care for HCV, pegylated interferon combined with ribavirin, may cause debilitating side effects(1) and cures only about half of patients starting therapy for the first time.(1)

The most common adverse events were headache and fatigue, 46 percent and 42 percent in the TMC435 groups and 51 percent and 47 percent in the placebo group respectively. There were no clinically significant differences in frequency of rash, anemia or gastrointestinal events between the TMC435 groups and placebo. Most AEs were mild to moderate in severity. AEs leading to treatment discontinuation were reported in 7.1 percent of patients in TMC435 arms and 7.8 percent in placebo arm.

In laboratory parameters, significant decreases in transaminases (ALT and AST) were observed in all treatment groups. Small and transient bilirubin elevations (direct and indirect) were seen in the TMC435 150mg dose groups.

"With a strong heritage in virology, Tibotec is committed to improving the lives of those impacted by HCV through the development of innovative new tre
'/>"/>

SOURCE Tibotec Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
3. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
4. LPBP Inc. - Re-filing certification of interim filings
5. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
6. Arpida Reports Interim Results for Six Months to 30 June 2008
7. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
8. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
9. Misonix Announces Interim Distribution Agreement for Italy
10. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
11. Interim Analysis of Data from e-HEALING Registry of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015 /PRNewswire/ - Fluorinov Pharma (Fluorinov), a FACIT portfolio ... Beshar to its Board of Directors.  His appointment ... expertise as Fluorinov accelerates its clinical development activities.  ... is a pleasure to welcome Luke to the Board ... the strategy, financial strength and success of multiple organizations," ...
(Date:5/26/2015)... SYDNEY and NEW YORK , May ... Limited (ASX:NRT; NASDAQ: NVGN ), announced today that it will ... May 28, 2015 in New York City ... by Dr. Graham Kelly , Novogen Chairman and CEO, is ... via a live webcast. To access the webcast, go to ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Just the ... a long-standing unmet biomedical need does not guarantee immediate ... problem that has seen many prior failures is often ... acceptance and use is an irony that is often ... small, new start-up company, Asymmetrex has found ...
(Date:5/25/2015)... Where is the universe expanding to? Global ... answer is that nobody is entirely sure." , Uldrich ... month of June, starting with the ULI Florida Leadership ... top tech trends. And one of the most intriguing ... is expanding to. According to Einstein’s theory of general ...
Breaking Biology Technology:Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 2Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 3Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 2Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 3
... J. Beck and C. Schmidt, Varian, Inc. , ... Marijuana is one of the most commonly ... the high from smoking marijuana is tetrahydrocannabinol or THC. Toxicology, forensic, and ... of one of the metabolites of THC, most frequently the carboxy form. ...
... D Garteiz, TexMS Analytical Services, Houston, TX , ... A Varian 1200L LC/MS/MS system was used for the quantitation ... to the urinary tract using a urethra suppository mode of administration. , ... is a major health problem in the U.S. and will continue to ...
... Activation of B cells through the B cell ... signaling pathway although, in many cases, different members of the same ... same family and have similar sequences and structures. Crosslinking of the ... which are Src family tyrosine kinases 1,2 . These kinases phosphorylate ...
Cached Biology Technology:Analysis of ()-11-Nor-9-Carboxy-Delta-9-THC in Urine by Negative Ion Electrospray LC/MS/MS 2Analysis of ()-11-Nor-9-Carboxy-Delta-9-THC in Urine by Negative Ion Electrospray LC/MS/MS 3Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System 2Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System 3Research Tools for Analysis of ZAP-70 2Research Tools for Analysis of ZAP-70 3
(Date:5/19/2015)... -- Fingerprint Cards (FPC) has received an order ... FPC1035 from one if its module partners. Deliveries are planned ... and the sensors will be used by smartphone manufacturers in ... hereby amount to 740 MSEK to date. In addition to ... a number of smaller orders not separately communicated amounting to ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated ... human interface solutions, today announced the appointment of ... and Chief Financial Officer, reporting to Rick ... Synaptics, current Chief Financial Officer, Kathleen Bayless ... Mr. Ali brings extensive financial ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... world are faced with two daunting tasks—maintaining rigorous levels ... In the years following the terrorist attacks of 9/11, ... U.S. but around the world. Most officials and passengers ... many security measures end up detaining passengers, or else ...
... Reconstructing the spread of killer diseases such as tuberculosis ... identifies the origin and movement of pathogens. This approach ... disease outbreaks, says a scientist speaking at the Society ... Warwick. A team from the British Columbia Centre ...
... have a reputation for being accommodating, but a new study ... a world-renowned park in Nepal are taking the night shift ... that tigers and people are sharing exactly the same space ... Chitwan National Park flies in the face of long-held convictions ...
Cached Biology News:Securiport: Biometric Scanning is Gold Standard in Airport Security 2TB outbreaks could be 'solved' by DNA tracking 2Tigers take the night shift to coexist with people 2Tigers take the night shift to coexist with people 3
... ABgene's Protein Purification Plates are designed for ... gels. The 96-well plates feature two 0.25mm ... of each well. The wells remain liquid-tight ... buffer, during which time the protein diffuses ...
... specifically for western blots ,• Optically clear ... for staining western blots. The reduced size ... the disposable tray requires less dye and ... to the user. Pour spouts in each ...
... The Gene Inspector can perform many sophisticated ... software is much more than just another sequence ... an entire suite of analyses to be performed ... to design custom style sheets which specify exactly ...
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens....
Biology Products: